Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients

NCT01155778 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis (MPS)

Interventions

BIOLOGICAL: Recombinant human heparan N-sulfatase (rhHNS)

Sponsor

Shire